(Q45882787)

17 December 2017

title

Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells (English)

1 reference

17 December 2017

0 references

2

1 reference

17 December 2017

author name string

D E Post

series ordinal

1

1 reference

17 December 2017

publication date

1 December 2001

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

8

1 reference

17 December 2017

issue

23

1 reference

17 December 2017

page(s)

1801-1807

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301605

exact match

0 references

cites work

Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301605

Hypoxia, clonal selection, and the role of HIF-1 in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301605

Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301605

Regulated expression of a foreign gene targeted to the ischaemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301605

Characterization of physiologically regulated vectors for the treatment of ischemic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301605

Development of a hypoxia-responsive vector for tumor-specific gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301605

Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301605

An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301605

The macrophage - a novel system to deliver gene therapy to pathological hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301605

Killing of brain tumor cells by hypoxia-responsive element mediated expression of BAX

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301605

A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301605

Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301605

Enhancement of gene expression under hypoxic conditions using fragments of the human vascular endothelial growth factor and the erythropoietin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301605

Co-regulation of two gene activities by tetracycline via a bidirectional promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301605

Targeting gene expression to hypoxic tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301605

21 January 2018

Identifiers

DOI

10.1038/SJ.GT.3301605

1 reference

17 December 2017

Dimensions Publication ID

1009497532

0 references

1 reference

17 December 2017